drugset / Trial / NCT05404724

Study on the Pharmacokinetic Effect of Itraconazole on SHR0302 Tablets in Healthy Subjects

NCT05404724

Phase 1 Completed 14 enrolled Jiangsu HengRui Medicine Co., Ltd.
NaSingle-groupOpen-labelBasic science

Summary

To evaluate the effect of oral itraconazole on the pharmacokinetics of SHR0302 in healthy subjects. To evaluate the safety and tolerability of oral SHR0302 and itraconazole monotherapy and combination use in healthy subjects.

Timeline

Start
2022-06-25
Primary completion
2022-07-11
Completion
2022-07-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Itraconazole Small molecule
Subject SHR0302 Unknown

Indications